Join
Live feed
·
PRReleasevia Quantisnow
AC Immune SA logo

AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104

ByQuantisnow·Wall Street's wire, on your screen.
ACIU· AC Immune SA
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACIU (AC Immune SA) and more on Quantisnow.